[
  {
    "ts": null,
    "headline": "A Scientist’s Final Quest Is to Find New Schizophrenia Drugs. Will He Live to See Them?",
    "summary": "A Scientist’s Final Quest Is to Find New Schizophrenia Drugs. Will He Live to See Them?",
    "url": "https://finnhub.io/api/news?id=d1f9de7ff251d2aa2e5e20c1857c625ead894c9d58e015e4e20890ea86152e22",
    "source": "DowJones",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732654800,
      "headline": "A Scientist’s Final Quest Is to Find New Schizophrenia Drugs. Will He Live to See Them?",
      "id": 131775655,
      "image": "",
      "related": "MRK",
      "source": "DowJones",
      "summary": "A Scientist’s Final Quest Is to Find New Schizophrenia Drugs. Will He Live to See Them?",
      "url": "https://finnhub.io/api/news?id=d1f9de7ff251d2aa2e5e20c1857c625ead894c9d58e015e4e20890ea86152e22"
    }
  },
  {
    "ts": null,
    "headline": "Merck & Co. (MRK) Fell As It Faced Some Demand Headwinds In China",
    "summary": "Columbia Threadneedle Investments, an investment management company released its “Columbia Dividend Opportunity Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. Equity markets rose again in the third quarter, helping most major indices finish near record levels in September. The fund’s investments rose across all sectors except energy, where […]",
    "url": "https://finnhub.io/api/news?id=a1a34b3ae451a239352d366f0b03a23babd5303aca0bf641683d052be1731b98",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732630308,
      "headline": "Merck & Co. (MRK) Fell As It Faced Some Demand Headwinds In China",
      "id": 131635575,
      "image": "https://media.zenfs.com/en/insidermonkey.com/4c2d50f14c73c26f6188d27970ea7976",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Columbia Threadneedle Investments, an investment management company released its “Columbia Dividend Opportunity Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. Equity markets rose again in the third quarter, helping most major indices finish near record levels in September. The fund’s investments rose across all sectors except energy, where […]",
      "url": "https://finnhub.io/api/news?id=a1a34b3ae451a239352d366f0b03a23babd5303aca0bf641683d052be1731b98"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Health Care Fund Q3 2024 Commentary",
    "summary": "Invesco Health Care Fund underperformed its benchmark. Despite earlier signs of improving trends, our health care outlook is bearish. Read more here.",
    "url": "https://finnhub.io/api/news?id=8811a159dd6bae05dcf408a9f48cd5d03a26ef619260c992cad970093f4bc185",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732624620,
      "headline": "Invesco Health Care Fund Q3 2024 Commentary",
      "id": 131646502,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/183355336/image_183355336.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Invesco Health Care Fund underperformed its benchmark. Despite earlier signs of improving trends, our health care outlook is bearish. Read more here.",
      "url": "https://finnhub.io/api/news?id=8811a159dd6bae05dcf408a9f48cd5d03a26ef619260c992cad970093f4bc185"
    }
  },
  {
    "ts": null,
    "headline": "Merck reports ‘positive’ results from Phase 3 ZENITH trial evaluating Winrevair",
    "summary": "Merck (MRK) announced positive topline results from the Phase 3 ZENITH study evaluating Winrevair in adults with pulmonary arterial hypertension functional class III or IV at high risk of mortality. ZENITH met its primary endpoint of time to first morbidity or mortality event. In the study, Winrevair demonstrated a statistically significant and clinically meaningful reduction in the risk of morbidity or mortality events compared to placebo, both on top of background PAH therapy. Based on the str",
    "url": "https://finnhub.io/api/news?id=1741a569f68d9205deb1c6e77c0e60f2052b3c80490122b89ef83f68be861ba6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732621834,
      "headline": "Merck reports ‘positive’ results from Phase 3 ZENITH trial evaluating Winrevair",
      "id": 131635576,
      "image": "https://media.zenfs.com/en/tipranks_452/c7cc0ee97ba22ee31ce2f6fcf51d1f91",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (MRK) announced positive topline results from the Phase 3 ZENITH study evaluating Winrevair in adults with pulmonary arterial hypertension functional class III or IV at high risk of mortality. ZENITH met its primary endpoint of time to first morbidity or mortality event. In the study, Winrevair demonstrated a statistically significant and clinically meaningful reduction in the risk of morbidity or mortality events compared to placebo, both on top of background PAH therapy. Based on the str",
      "url": "https://finnhub.io/api/news?id=1741a569f68d9205deb1c6e77c0e60f2052b3c80490122b89ef83f68be861ba6"
    }
  },
  {
    "ts": null,
    "headline": "Merck to Participate in the Citi 2024 Global Healthcare Conference",
    "summary": "RAHWAY, N.J., November 26, 2024--Merck to Participate in the Citi 2024 Global Healthcare Conference",
    "url": "https://finnhub.io/api/news?id=cc8f52d14ace46dbe7984e1fa05035f9bbbc10a153b1f85b1ec1f422cd057d17",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732621500,
      "headline": "Merck to Participate in the Citi 2024 Global Healthcare Conference",
      "id": 131635578,
      "image": "https://media.zenfs.com/en/business-wire.com/1f65aa959553e9e61b0a86f3378a44a9",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., November 26, 2024--Merck to Participate in the Citi 2024 Global Healthcare Conference",
      "url": "https://finnhub.io/api/news?id=cc8f52d14ace46dbe7984e1fa05035f9bbbc10a153b1f85b1ec1f422cd057d17"
    }
  },
  {
    "ts": null,
    "headline": "Amgen, Boeing share losses lead Dow's 200-point fall",
    "summary": "Amgen, Boeing share losses lead Dow's 200-point fall",
    "url": "https://finnhub.io/api/news?id=81e02a280eef9cad20a7b97d41b9c68ec485d9d91fc0999a95b19d0907fe0f57",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732614300,
      "headline": "Amgen, Boeing share losses lead Dow's 200-point fall",
      "id": 131636896,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Amgen, Boeing share losses lead Dow's 200-point fall",
      "url": "https://finnhub.io/api/news?id=81e02a280eef9cad20a7b97d41b9c68ec485d9d91fc0999a95b19d0907fe0f57"
    }
  },
  {
    "ts": null,
    "headline": "Invesco Equity And Income Fund Q3 2024 Commentary",
    "summary": "The fund holds high-grade bonds and convertible securities as a source of income and to help provide a measure of stability in volatile markets.",
    "url": "https://finnhub.io/api/news?id=87ab91299af1405d674e3167edc6d5195c32df8775ce32d0e978e4c48282122f",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1732602300,
      "headline": "Invesco Equity And Income Fund Q3 2024 Commentary",
      "id": 131631071,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1562199023/image_1562199023.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "The fund holds high-grade bonds and convertible securities as a source of income and to help provide a measure of stability in volatile markets.",
      "url": "https://finnhub.io/api/news?id=87ab91299af1405d674e3167edc6d5195c32df8775ce32d0e978e4c48282122f"
    }
  }
]